General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Echo IQ(SIGNIFICANT) SPEAKER'S BUREAU: Novo Nordisk Inc.(SIGNIFICANT), GlaxoSmithKline(SIGNIFICANT), CSL Seqirus(SIGNIFICANT) OFFICER, DIRECTOR ETC: National Echo Database Australia(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Pfizer Inc(NONE), Edwards LifeSciences(NONE), Western Australian Government(NONE), Bristol Myer Squibb Pharmaceuticals(NONE), AstraZeneca(NONE), Novartis Corporation(NONE)

View Full Disclosure